Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neubase Therapeutics, Inc. (OHRP) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neubase Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1173281.
Total stock buying since 2014: $1,520,465.
Total stock sales since 2014: $712,348.
Total stock option exercises since 2014: $2,843.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 61,076 | $59,732 | 489,520 | $712,348 | 748,234 | $2,051 |
| 2022 | 40,080 | $69,956 | 0 | $0 | 750,000 | $750 |
| 2021 | 29,000 | $145,000 | 0 | $0 | 42,250 | $42 |
| 2020 | 34,358 | $210,969 | 0 | $0 | 0 | $0 |
| 2017 | 357,145 | $250,000 | 0 | $0 | 0 | $0 |
| 2016 | 115,520 | $353,041 | 0 | $0 | 0 | $0 |
| 2015 | 57,185 | $327,909 | 0 | $0 | 0 | $0 |
| 2014 | 13,300 | $103,858 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-09 | 61,076 | $59,732 | 489,520 | $712,348 | 0 | $0 |
| 2023-08 | 0 | $0 | 0 | $0 | 93,234 | $2,051 |
| 2023-02 | 0 | $0 | 0 | $0 | 655,000 | $0 |
| 2022-09 | 0 | $0 | 0 | $0 | 750,000 | $750 |
| 2022-03 | 40,080 | $69,956 | 0 | $0 | 0 | $0 |
| 2021-12 | 0 | $0 | 0 | $0 | 42,250 | $42 |
| 2021-04 | 29,000 | $145,000 | 0 | $0 | 0 | $0 |
| 2020-06 | 1,275 | $9,860 | 0 | $0 | 0 | $0 |
| 2020-05 | 1,250 | $10,111 | 0 | $0 | 0 | $0 |
| 2020-04 | 31,833 | $190,998 | 0 | $0 | 0 | $0 |
| 2017-04 | 357,145 | $250,000 | 0 | $0 | 0 | $0 |
| 2016-06 | 56,270 | $159,645 | 0 | $0 | 0 | $0 |
| 2016-05 | 34,250 | $107,860 | 0 | $0 | 0 | $0 |
| 2016-04 | 6,250 | $20,937 | 0 | $0 | 0 | $0 |
| 2016-03 | 6,250 | $22,300 | 0 | $0 | 0 | $0 |
| 2016-02 | 6,250 | $19,468 | 0 | $0 | 0 | $0 |
| 2016-01 | 6,250 | $22,831 | 0 | $0 | 0 | $0 |
| 2015-12 | 3,000 | $12,210 | 0 | $0 | 0 | $0 |
| 2015-11 | 13,350 | $40,064 | 0 | $0 | 0 | $0 |
| 2015-02 | 40,835 | $275,635 | 0 | $0 | 0 | $0 |
| 2014-09 | 2,200 | $17,779 | 0 | $0 | 0 | $0 |
| 2014-07 | 1,000 | $8,400 | 0 | $0 | 0 | $0 |
| 2014-06 | 10,100 | $77,679 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-18 | Symetryx Corp (10% Owner) | Sale | 50,000 | 1.19 | 59,500 |
| 2023-09-15 | Symetryx Corp (10% Owner) | Sale | 103,337 | 1.26 | 130,204 |
| 2023-09-14 | Symetryx Corp (10% Owner) | Sale | 129,108 | 1.44 | 185,915 |
| 2023-09-11 | Symetryx Corp (10% Owner) | Sale | 3,376 | 1.44 | 4,861 |
| 2023-09-08 | Symetryx Corp (10% Owner) | Sale | 128,847 | 1.53 | 197,135 |
| 2023-09-07 | Symetryx Corp (10% Owner) | Sale | 74,852 | 1.80 | 134,733 |
| 2023-09-01 | Symetryx Corp (10% Owner) | Buy | 61,076 | .98 | 59,732 |
| 2023-08-02 | Stephan Dietrich A (Founder and CEO) | Option Ex | 93,234 | .02 | 2,051 |
| 2023-02-13 | Stephan Dietrich A (President and CEO) | Option Ex | 655,000 | .00 | 0 |
| 2022-09-28 | Stephan Dietrich A (CEO) | Option Ex | 750,000 | .00 | 750 |
| 2022-03-30 | Mann William Roland (Chief Operating Officer) | Buy | 6,200 | 1.92 | 11,904 |
| 2022-03-18 | Branning Todd P. (Chief Financial Officer) | Buy | 10,000 | 1.81 | 18,100 |
| 2022-03-17 | Branning Todd P. (Chief Financial Officer) | Buy | 10,000 | 1.74 | 17,400 |
| 2022-03-16 | Branning Todd P. (Chief Financial Officer) | Buy | 10,000 | 1.62 | 16,200 |
| 2022-03-04 | Richman Eric I | Buy | 1,000 | 1.62 | 1,620 |
| 2022-03-03 | Richman Eric I | Buy | 1,300 | 1.72 | 2,236 |
| 2022-03-01 | Richman Eric I | Buy | 1,580 | 1.58 | 2,496 |
| 2021-12-31 | Stephan Dietrich A (President and CEO) | Option Ex | 42,250 | .00 | 42 |
| 2021-04-26 | Mann William Roland (COO) | Buy | 5,000 | 5.00 | 25,000 |
| 2021-04-26 | Stephan Dietrich A (President and CEO) | Buy | 12,000 | 5.00 | 60,000 |
| 2021-04-26 | Goldstein Dov A Md | Buy | 12,000 | 5.00 | 60,000 |
| 2020-06-09 | Lipizzaner Llc | Buy | 1,275 | 7.73 | 9,860 |
| 2020-05-21 | Lipizzaner Llc | Buy | 1,250 | 8.09 | 10,111 |
| 2020-04-30 | Lipizzaner Llc | Buy | 10,000 | 6.00 | 60,000 |
| 2020-04-30 | Backenroth Samuel (CFO, Treasurer & Secretary) | Buy | 1,000 | 6.00 | 6,000 |
| 2020-04-30 | Richman Eric I | Buy | 10,833 | 6.00 | 64,998 |
| 2020-04-30 | Goldstein Dov A Md | Buy | 10,000 | 6.00 | 60,000 |
| 2017-04-10 | Slakter Jason Scott (Chief Executive Officer) | Buy | 142,858 | .70 | 100,000 |
| 2017-04-10 | Backenroth Samuel (Chief Financial Officer) | Buy | 71,429 | .70 | 50,000 |
| 2017-04-10 | Hirschman Orin | Buy | 142,858 | .70 | 100,000 |
| 2016-06-20 | Slakter Jason Scott (Chief Executive Officer) | Buy | 26,358 | 2.84 | 74,775 |
| 2016-06-20 | Backenroth Samuel (Chief Financial Officer) | Buy | 7,404 | 2.84 | 21,012 |
| 2016-05-25 | Slakter Jason Scott (Chief Executive Officer) | Buy | 3,682 | 3.12 | 11,480 |
| 2016-05-24 | Slakter Jason Scott (Chief Executive Officer) | Buy | 7,503 | 3.11 | 23,334 |
| 2016-05-23 | Slakter Jason Scott (Chief Executive Officer) | Buy | 20,565 | 3.17 | 65,129 |
| 2016-05-23 | Backenroth Samuel (Chief Financial Officer) | Buy | 2,500 | 3.17 | 7,917 |
| 2016-04-11 | Slakter Jason Scott (Chief Executive Officer) | Buy | 6,250 | 3.35 | 20,937 |
| 2016-03-07 | Slakter Jason Scott (Chief Executive Officer) | Buy | 6,250 | 3.57 | 22,300 |
| 2016-02-22 | Slakter Jason Scott (Chief Executive Officer) | Buy | 6,250 | 3.12 | 19,468 |
| 2016-01-19 | Slakter Jason Scott (Chief Executive Officer) | Buy | 6,250 | 3.65 | 22,831 |
| 2015-12-07 | Slakter Jason Scott (Chief Executive Officer) | Buy | 3,000 | 4.07 | 12,210 |
| 2015-11-03 | Slakter Jason Scott (Chief Executive Officer) | Buy | 100 | 3.01 | 301 |
| 2015-11-02 | Slakter Jason Scott (Chief Executive Officer) | Buy | 13,250 | 3.00 | 39,763 |
| 2015-02-06 | Slakter Jason Scott | Buy | 29,630 | 6.75 | 200,002 |
| 2015-02-06 | Taraporewala Irach B. (Chief Executive Officer) | Buy | 3,705 | 6.75 | 25,008 |
| 2015-02-06 | Backenroth Samuel (Chief Financial Officer) | Buy | 1,500 | 6.75 | 10,125 |
| 2015-02-06 | Almenoff June Sherie | Buy | 6,000 | 6.75 | 40,500 |
| 2014-09-03 | Almenoff June Sherie | Buy | 1,200 | 8.05 | 9,660 |
| 2014-09-02 | Almenoff June Sherie | Buy | 1,000 | 8.12 | 8,119 |
| 2014-07-02 | Greenstein Ira A | Buy | 1,000 | 8.40 | 8,400 |
| 2014-06-26 | Almenoff June Sherie | Buy | 3,200 | 8.34 | 26,688 |
| 2014-06-25 | Riedhammer Thomas M | Buy | 6,900 | 7.39 | 50,991 |
Insider trading activities including stock purchases, stock sales, and option exercises of OHRP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neubase Therapeutics, Inc. (symbol OHRP, CIK number 1173281) see the Securities and Exchange Commission (SEC) website.